262 related articles for article (PubMed ID: 27438792)
1. Intraocular Lymphoma: Descriptive Data of 26 Patients Including Clinico-pathologic Features, Vitreous Findings, and Treatment Outcomes.
Abu Samra K; Oray M; Ebrahimiadib N; Lee S; Anesi S; Foster CS
Ocul Immunol Inflamm; 2018; 26(3):347-352. PubMed ID: 27438792
[TBL] [Abstract][Full Text] [Related]
2. Vitreoretinal presentation of secondary large B-cell lymphoma in patients with systemic lymphoma.
Salomão DR; Pulido JS; Johnston PB; Canal-Fontcuberta I; Feldman AL
JAMA Ophthalmol; 2013 Sep; 131(9):1151-8. PubMed ID: 23744124
[TBL] [Abstract][Full Text] [Related]
3. Intraocular T-cell Lymphoma: Clinical Presentation, Diagnosis, Treatment, and Outcome.
Chaput F; Amer R; Baglivo E; Touitou V; Kozyreff A; Bron D; Bodaghi B; LeHoang P; Bergstrom C; Grossniklaus HE; Chan CC; Pe'er J; Caspers LE
Ocul Immunol Inflamm; 2017 Oct; 25(5):639-648. PubMed ID: 27002464
[TBL] [Abstract][Full Text] [Related]
4. Clinical Features and Treatment Outcomes of Vitreoretinal Lymphoma according to Its Association with CNS Lymphoma.
Cho BJ; Kim DY; Park UC; Lee JY; Yoon YH; Yu HG
Ocul Immunol Inflamm; 2018; 26(3):365-371. PubMed ID: 29394118
[TBL] [Abstract][Full Text] [Related]
5. Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes.
Akpek EK; Ahmed I; Hochberg FH; Soheilian M; Dryja TP; Jakobiec FA; Foster CS
Ophthalmology; 1999 Sep; 106(9):1805-10. PubMed ID: 10485554
[TBL] [Abstract][Full Text] [Related]
6. Primary vitreoretinal natural killer/T-cell lymphoma with breast involvement: A case report and review of the literature.
Gao S; Zhou Y; Jin X; Lin Z; Zhong Y; Shen X
Surv Ophthalmol; 2019; 64(2):225-232. PubMed ID: 30321569
[TBL] [Abstract][Full Text] [Related]
7. Tumor Control and Visual Acuity Outcomes in Vitreoretinal Lymphoma with and without Sub-Retinal Pigment Epithelium Infiltration: Analysis of 125 Eyes of 70 Patients at a Single Ocular Oncology Center.
Dalvin LA; Lim LS; Ancona-Lezama D; Mazloumi M; Chang M; Mashayekhi A; Shields CL
Ophthalmol Retina; 2019 Nov; 3(11):998-1005. PubMed ID: 31358444
[TBL] [Abstract][Full Text] [Related]
8. How we diagnose and treat vitreoretinal lymphoma.
Fend F; Ferreri AJ; Coupland SE
Br J Haematol; 2016 Jun; 173(5):680-92. PubMed ID: 27133587
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and diagnostic significance of the intraocular fluid of 217 patients with intraocular lymphoma.
Kimura K; Usui Y; Goto H;
Jpn J Ophthalmol; 2012 Jul; 56(4):383-9. PubMed ID: 22661396
[TBL] [Abstract][Full Text] [Related]
10. Retrospective cytological study of intraocular lymphoma using vitreous and intraocular perfusion fluid.
Kinoshita Y; Takasu K; Adachi Y; Yuri T; Nagumo S; Shikata N
Diagn Cytopathol; 2012 Jul; 40(7):604-7. PubMed ID: 22707324
[TBL] [Abstract][Full Text] [Related]
11. Two types of initial ocular manifestations in intraocular-central nervous system lymphoma.
Matsuo T; Yamaoka A; Shiraga F; Matsuo N
Retina; 1998; 18(4):301-7. PubMed ID: 9730171
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic vitrectomy for vitreal recurrence of intraocular lymphoma resistant to intravitreal methotrexate post systemic chemotherapy.
Venkatesh P; Gogia V; Khanduja S; Gupta S; Kumar L; Garg S
J Cancer Res Ther; 2015; 11(3):668. PubMed ID: 26458712
[TBL] [Abstract][Full Text] [Related]
13. Clinical Characteristics of Primary Vitreoretinal Lymphoma in an Indian Population.
Mahajan S; Nijhawan R; Rajwanshi A; Karkhur S; Mulkutar S; Dogra M; Lal V; Gupta V; Gupta A
Ocul Immunol Inflamm; 2017 Oct; 25(5):633-638. PubMed ID: 27003620
[TBL] [Abstract][Full Text] [Related]
14. Vitreoretinal lymphoma: changing trends in diagnosis and local treatment modalities at a single institution.
Turaka K; Bryan JS; De Souza S; Gordon AJ; Kwong HM; Ziemianski MC; Reddy R; Sell CH
Clin Lymphoma Myeloma Leuk; 2012 Dec; 12(6):412-7. PubMed ID: 22995952
[TBL] [Abstract][Full Text] [Related]
15. Vitreoretinal lymphoma: a 20-year review of incidence, clinical and cytologic features, treatment, and outcomes.
Levasseur SD; Wittenberg LA; White VA
JAMA Ophthalmol; 2013 Jan; 131(1):50-5. PubMed ID: 23307208
[TBL] [Abstract][Full Text] [Related]
16. Primary Vitreoretinal Lymphoma in HIV Infection.
Steffen J; Coupland SE; Smith JR
Ocul Immunol Inflamm; 2021 Apr; 29(3):621-627. PubMed ID: 32453669
[No Abstract] [Full Text] [Related]
17. Evaluation of vitrectomy specimens and chorioretinal biopsies in the diagnosis of primary intraocular lymphoma in patients with Masquerade syndrome.
Coupland SE; Bechrakis NE; Anastassiou G; Foerster AM; Heiligenhaus A; Pleyer U; Hummel M; Stein H
Graefes Arch Clin Exp Ophthalmol; 2003 Oct; 241(10):860-70. PubMed ID: 14605902
[TBL] [Abstract][Full Text] [Related]
18. CLINICAL FEATURES, DIAGNOSTIC SIGNIFICANCE, AND PROGNOSIS OF VITREORETINAL LYMPHOMA IN YOUNG PATIENTS.
Liu S; Gu J; Zhang T; Ping B; Zhou M; Huang X; Jiang R; Xu G; Chang Q
Retina; 2021 Dec; 41(12):2596-2604. PubMed ID: 34173362
[TBL] [Abstract][Full Text] [Related]
19. HISTOLOGIC FINDINGS IN VITREORETINAL LYMPHOMA: Learning From Enucleation Specimens.
Albadri ST; Pulido JS; Macon WR; Garcia JJ; Salomao DR
Retina; 2020 Feb; 40(2):391-398. PubMed ID: 31972811
[TBL] [Abstract][Full Text] [Related]
20. An unusual case report of primary vitreoretinal lymphoma.
Tan SZ; Steeples LR; Chhabra R; Jones NP
BMC Ophthalmol; 2018 Sep; 18(Suppl 1):223. PubMed ID: 30255824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]